Medicines Co (MDCO) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts MDCO Hot Sheet
Join SI Premium – FREE
Medicines Co (NASDAQ: MDCO) reported Q2 non-GAAP EPS of $0.24, $0.04 better than the analyst estimate of $0.20. Revenue for the quarter came in at $119.6 million versus the consensus estimate of $117.66 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
